When Genentech licensed experimental drug vixarelimab from Kiniksa Pharmaceuticals KNSA-1.57%decrease; red down pointing triangle, its scientists thought they had a future lung medicine in their ...

For big pharma companies, blockbuster drugs can feel like a double-edged sword. Their discovery brings huge excitement and share price gains in anticipation of the cash that will soon roll in.

In a report released today, Vikram Purohit from Morgan Stanley maintained a Hold rating on Ascendis Pharma (ASND – Research Report), with a price target of $175.00. The company’s shares closed ...

In 2018, 16 of the top 20 publicly traded pharmaceutical players globally reported year-on-year growth in their revenue, with three companies – Takeda, Celgene (currently under a merger ...

The pharma companies made drugs that could help patients and spent lots of time telling doctors which drugs to give to who. Then payers came along and started scrutinising how much was being spent ...

Perform material- and labor-effective extrusion with Thermo Scientific™ Pharma 11 Twin-screw Extruder, which requires only a small amount of active pharmaceutical ingredient, operating at ...

Wockhardt: The pharma company returned to black as it reported a net profit of Rs 14 crore for the December 2024 quarter, a significant comeback from the Rs 83 crore loss in the year ago period.

MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based ...

Companies that have grown profits and net profit margins over the past 12 months ...

3382.T Seven & i Holdings Co., Ltd.